肝细胞癌中的放射电阻:生物学基础和治疗影响
Jianhui Wu1,2, Xiaofang Zhao1,2, Bowen Ren2
1Department of Radiation Oncology, The Fifth Medical Center of PLA General Hospital, Beijing 100039, China.
International journal of molecular sciences
|March 13, 2025
概括
肝细胞癌 (HCC) 治疗面临由于放射电阻的挑战. 了解抗辐射的分子机制是改善肝癌放射治疗有效性的关键.
科学领域:
- 肝细胞癌 (HCC) 研究研究
- 放射治疗和瘤学
- 癌症耐药性的分子机制
背景情况:
- 肝细胞癌 (HCC) 由于高发病率和死亡率,给全球健康带来了重大挑战.
- 放射治疗是HCC各个阶段广泛使用的治疗方式.
- 患者对放射治疗的耐药性是一个主要的临床限制,阻碍了治疗疗效,需要进一步的研究.
研究的目的:
- 提供对放射治疗在HCC中的作用机制的全面概述.
- 阐明HCC中放射电阻的细胞和分子基础.
- 探索当前的治疗方法和克服HCC电阻的未来前景.
主要方法:
- 对HCC的放射治疗机制的文献综述.
- 对导致HCC电阻的分子因素的分析.
- 综合有关当前和未来治疗策略的信息.
主要成果:
- 放射治疗在HCC的疗效受到内在和获得的放射电阻的显著影响.
- 影响HCC辐射敏感性的关键因素包括DNA修复,自,细胞循环,新陈代谢和缺氧.
- 了解这些分子机制对于开发逆转放射电阻的策略至关重要.
结论:
- 克服放射电阻对于推进HCC放射治疗至关重要.
- 针对参与DNA修复,自,细胞循环,新陈代谢和缺氧的特定分子通路,有望提高治疗结果.
- 对HCC电阻的分子基础的进一步研究对于未来的治疗突破至关重要.
相关概念视频
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


